These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3132622)

  • 21. [Study of "lupus-type" anticoagulant using diluted Russell's viper venom time. Study of 16 patients].
    Pardo Vigo A; Oteyza JP; Blanco L; Correa MA; César J; Avello AG; Frade JG; Navarro JL
    Sangre (Barc); 1987; 32(2):231-5. PubMed ID: 3112970
    [No Abstract]   [Full Text] [Related]  

  • 22. Assays for lupus anticoagulant: the sensitivity of different assays.
    Jain A; Dash S; Marwaha N; Deodhar SD; Sehgal S
    Med Lab Sci; 1991 Jan; 48(1):31-5. PubMed ID: 1905773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common variable immune deficiency syndrome associated with lupus anticoagulant.
    Ruggieri AP; Galbraith RM; Lazarchick J
    Clin Exp Rheumatol; 1985; 3(1):71-3. PubMed ID: 3919983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders.
    Asherson RA; Khamashta MA; Baguley E; Oakley CM; Rowell NR; Hughes GR
    Q J Med; 1989 Dec; 73(272):1103-15. PubMed ID: 2515555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurology and the lupus anticoagulant.
    Englert H; Derue G; Hughes GR
    Eur Neurol; 1985; 24(6):422-5. PubMed ID: 3933980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract]   [Full Text] [Related]  

  • 27. Central retinal-artery occlusion in a patient with circulating lupus anticoagulant.
    Reisin LH; Reisin I; Darawshi A; Aviel E
    Ann Ophthalmol; 1989 Jul; 21(7):269-71. PubMed ID: 2505658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus anticoagulant and Waldenstrom's macroglobulinemia.
    Maldonado N; González A; Asmar S; Robert F; Cruz Vidal M; Fraguada L
    Bol Asoc Med P R; 1988 Nov; 80(11):408-12. PubMed ID: 3146257
    [No Abstract]   [Full Text] [Related]  

  • 29. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar V
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance of antiphosphatidylserine antibodies in patients with lupus anticoagulant. Analysis of 30 cases].
    Zuazu-Jausoro I; Oliver A; Monserrat I; Borrell M; Garí M; Pich I; Grau E; Fontcuberta J
    Med Clin (Barc); 1990 Jul; 95(6):210-3. PubMed ID: 2123507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis].
    Zea Mendoza A; Rodríguez García A; Irigoyen Oyarzábal MV; Vázquez Díaz M; Pardo Vigo A; Mampaso FM; Ortuño Mirete J
    Med Clin (Barc); 1989 May; 92(19):724-8. PubMed ID: 2502695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation.
    Schorer AE; Wickham NW; Watson KV
    Br J Haematol; 1989 Mar; 71(3):399-407. PubMed ID: 2495019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma requirement for expression of lupus-like anticoagulant.
    Clyne LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):841-4. PubMed ID: 2436999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lupus-type anticoagulants and thromboses].
    Sultan Y
    Ann Med Interne (Paris); 1986; 137(6):475-6. PubMed ID: 3101565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients.
    Phillips AO; Jones HW; Hambley H; Hillis AN; Hendry BM
    Nephron; 1993; 65(3):350-3. PubMed ID: 8289982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lupus anticoagulant and recurrent transient ischemic attacks].
    Guerrero A; García-Ruiz P; Bañares A; Rubio M; Escribá A; García-Urra D; Varela de Seijas E
    Neurologia; 1989; 4(6):216-8. PubMed ID: 2517779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis.
    Vaziri ND; Toohey J; Paule P; Alikhani S; Hung E
    Int J Artif Organs; 1984 Nov; 7(6):323-6. PubMed ID: 6526526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The antiphospholipid antibody syndrome: its pathogenesis and clinico-morphological manifestations].
    Zerbino DD; Lukasevich LL; Bilynskaia OA
    Arkh Patol; 1990; 52(4):65-9. PubMed ID: 2117434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and quantitative evaluation of lupus circulating anticoagulant activity.
    Rosner E; Pauzner R; Lusky A; Modan M; Many A
    Thromb Haemost; 1987 Apr; 57(2):144-7. PubMed ID: 3110995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.